Skip to content
healthcare.dev

doxorubicin hydrochloride

NDC 75907-364, doxorubicin hydrochloride, injection, suspension, liposomal, from Dr. Reddy's Laboratories Inc..

Product NDC
75907-364
Status
Listed
Labeler
Dr. Reddy's Laboratories Inc.
Dosage form
INJECTION, SUSPENSION, LIPOSOMAL
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219199
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/75907-364 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXORUBICIN HYDROCHLORIDE2 mg/mL

Pharmacologic classes

Anthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
75907-364-01759070364011 VIAL, SINGLE-DOSE in 1 CARTON (75907-364-01) / 25 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0885dddf-727e-4692-92dd-a26c69cc278d
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=75907-364

Use it

Look up 75907-364 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/75907-364 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 75907-364. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.